MapLight Therapeutics (MPLT) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 23, 2026, to be held virtually for stockholders of record as of April 27, 2026.

• Meeting materials, including the proxy statement and annual report, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of three Class I Director nominees to serve until the 2029 annual meeting: Martin Babler, Troy Cox, and George Pavlov.

• Ratification of RSM US LLP as the independent registered public accounting firm for the year ending December 31, 2026.

• Provision to conduct any other business properly brought before the meeting or its adjournment.

Board of directors and corporate governance

• Board recommends voting FOR each director nominee and FOR the ratification of the auditor.